Quick Answer
Outset Medical, Inc. reported Total Revenue of $119.48 million for the year ending 2025.
- Outset Medical, Inc. showed an increase of +5.1% in Total Revenue from 2024 to 2025.
- This data is from Outset Medical, Inc.'s annual report (Form 10-K), filed with the SEC on February 13, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: $2.49 million | Q2 2019: $2.87 million | Q3 2019: $2.63 million | Q4 2019: $7.09 million | Q1 2020: $7.19 million | Q2 2020: $11.74 million | Q3 2020: $13.76 million | Q4 2020: $17.25 million | Q1 2021: $22.92 million | Q2 2021: $25.22 million | Q3 2021: $26.32 million | Q1 2022: $30.55 million | Q2 2022: $25.06 million | Q3 2022: $27.76 million | Q1 2023: $33.47 million | Q2 2023: $36.04 million | Q3 2023: $30.36 million | Q1 2024: $28.17 million | Q2 2024: $27.39 million | Q3 2024: $28.67 million | Q1 2025: $29.75 million | Q2 2025: $31.42 million | Q3 2025: $29.43 million.
- Over the full 8 years of available data (2018 to 2025), Outset Medical, Inc.'s Total Revenue has grown by 5,853.0%.
- Historical annual values: Fiscal year 2025: $119.48 million | Fiscal year 2024: $113.69 million | Fiscal year 2023: $130.38 million | Fiscal year 2022: $115.38 million | Fiscal year 2021: $102.60 million | Fiscal year 2020: $49.94 million | Fiscal year 2019: $15.08 million | Fiscal year 2018: $2.01 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: